HOME >> MEDICINE >> NEWS
Cancer drug is first to alleviate devastating scleroderma symptoms

BACKGROUND:
Scleroderma is a debilitating autoimmune disease that attacks the connective tissues and especially the lungs. Hardening of the skin is one of the most visible effects of the disease. Over 40 percent of patients will develop symptomatic lung problems the leading cause of death for scleroderma patients.

FINDINGS:
A new nationwide study headed by UCLA found that a drug used for cancer called cyclophosphamide, helped alleviate the serious effects of scleroderma on breathing, lung function, quality of life, functional disability and skin thickness. This is the first controlled clinical trial to show a positive treatment for scleroderma lung disease.

IMPACT:
Findings will help researchers develop new drug therapies and also better understand development of the disease. The next step is further research into use of cylophosphamide as well as other immunosuppressant drugs.

AUTHORS:
Drs. Donald Tashkin and Michael Roth, professors of pulmonary and critical care medicine; and Drs. Philip Clements and Daniel Furst, professors of rheumatology, David Geffen School of Medicine at UCLA.


'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-2270
University of California - Los Angeles
21-Jun-2006


Page: 1

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
8. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
9. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
10. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
11. Cancer-fighting foods, supplements explored in day-long symposium, March 25

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer drug first alleviate devastating scleroderma symptoms

(Date:8/28/2014)... Alexandria, VA (PRWEB) August 28, 2014 ... Foundation (Meso Foundation) is able to accept donations in ... give. The Bitcoin donation page can be found at ... businesses are accepting Bitcoin as a form of payment, ... the same,” said Meso Foundation’s chief executive officer, Melinda ...
(Date:8/28/2014)... an internationally famous designer and leader in the formal ... fall bridesmaid dresses for the global clients. ... is now providing big discounts for all these trendy ... are offered in many fashionable colours. A lot of ... $190. UWDress.com’s kind officials always take everyone’s budget into ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 HORNE LLP ... of the accounting industry. The $67 million firm has ... the industry may hang in the balance. , Described ... storm,” a mass exit of Baby Boomers creating succession ... high turnover rates are creating culture wars within firms ...
(Date:8/28/2014)... women who are given information about the chance of ... fully understand the risks involved, according to research published ... today (Friday). , In a survey of around 2,200 ... (UCL) found that 64 per cent felt they fully ... that screening will pick up cancers that would never ...
(Date:8/28/2014)... FL (PRWEB) August 28, 2014 ... Recovery Month throughout September. This month will be ... treatment and mental health services. Along with other ... Group is helping to spread the word about ... in 1989, honoring the work of treatment and ...
Breaking Medicine News(10 mins):Health News:Cancer Research Funding Organization Now Accepts Bitcoin Donations 2Health News:Fashionable Fall Bridesmaid Dresses From UWDress.com 2Health News:HORNE LLP Proclaims War on Accounting Firm Culture 2Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2
(Date:8/28/2014)... CHARLOTTE, N.C. , Aug. 28, 2014 /PRNewswire/ ... innovation marketplace, today announced a worldwide search for ... of the senior population.  Promising ideas uncovered through ... presented to leading medical device manufacturers and healthcare ... to improve the lives of individuals age 65 ...
(Date:8/28/2014)... 2014 /PRNewswire-iReach/ -- Gateway Analytical announced today that ... Annual Global Pharma Manufacturing Summit in ... . The Global Pharma Manufacturing Summit offers a ... and biologic pharmaceutical manufacturing. The conference is focused ... face, such as the increasing pressure to grow ...
(Date:8/28/2014)... DIEGO , Aug. 28, 2014 Telik, ... development company that merged with MabVax Therapeutics, Inc. ... made significant progress related to the development of ... antibody was recovered using the Company,s internally developed ... the potential for multiple antibody based therapeutic and ...
Breaking Medicine Technology:Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
Cached News: